We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

402 hedge funds and large institutions have $7.78B invested in United Therapeutics in 2021 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 117 increasing their positions, 160 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $48.6M | Put options by funds: $22.8M

35% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 40

7% more capital invested

Capital invested by funds: $7.28B → $7.78B (+$507M)

3% more funds holding

Funds holding: 391 → 402 (+11)

0.58% less ownership

Funds ownership: 97.82% → 97.24% (-0.58%)

19% less funds holding in top 10

Funds holding in top 10: 16 → 13 (-3)

27% less repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 160

Holders
402
Holders Change
+11
Holders Change %
+2.81%
% of All Funds
7%
Holding in Top 10
13
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-18.75%
% of All Funds
0.23%
New
54
Increased
117
Reduced
160
Closed
40
Calls
$48.6M
Puts
$22.8M
Net Calls
+$25.8M
Net Calls Change
+$19.5M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$105M
2
PA
Perceptive Advisors
New York
+$84.1M
3
VOYA Investment Management
VOYA Investment Management
Georgia
+$53.2M
4
APM
Avidity Partners Management
Texas
+$45M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$42M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$76M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$55.8M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$46.5M
4
MWNA
Marshall Wace North America
New York
-$45.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$33.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
376
Sugarloaf Wealth Management
Georgia
$8K – – –
FF
377
FourThought Financial
Florida
$7K – – –
IA
378
IFP Advisors
Florida
$7K – – –
MPWT
379
MassMutual Private Wealth & Trust
Connecticut
$7K – – –
ACM
380
AUA Capital Management
Pennsylvania
$7K +$381 +2 +5%
APC
381
Aspire Private Capital
North Carolina
$6K -$381 -2 -6%
GRP
382
Global Retirement Partners
California
$6K – – –
TCM
383
Tradewinds Capital Management
Washington
$6K – – –
WQ
384
Wealth Quarterback
New Jersey
$6K +$5.52K +29 New
EFSCE
385
Enterprise Financial Services Corp (EFSC)
Missouri
$5K – – –
HIA
386
Harbor Investment Advisory
Maryland
$5K – – –
PCG
387
Private Capital Group
Connecticut
$4K – – –
GWM
388
Geneos Wealth Management
Colorado
$4K +$4.57K +24 New
Nisa Investment Advisors
389
Nisa Investment Advisors
Missouri
$3.37K -$476K -2,500 -12%
BC
390
Bartlett & Co
Ohio
$3K – – –
LC
391
Lindbrook Capital
California
$3K – – –
TWM
392
Tradition Wealth Management
Minnesota
$3K +$3.62K +19 New
BCWM
393
Bartlett & Co Wealth Management
Ohio
$2.87K – – –
SCM
394
Silverarc Capital Management
Massachusetts
$2.74K +$1.89M +9,925 +185%
EARNEST Partners
395
EARNEST Partners
Georgia
$2K – – –
PFGIA
396
Patriot Financial Group Insurance Agency
Massachusetts
$2K – – –
AWA
397
Arkadios Wealth Advisors
Georgia
$2K +$2.29K +12 New
APA
398
American Portfolios Advisors
New York
$1.44K -$381 -2 -20%
PWMG
399
Prestige Wealth Management Group
New Jersey
$1K – – –
FMP
400
Financial Management Professionals
Texas
$1K +$762 +4 New
14 15
16
17 18

UTHR Hedge Fund Activity: Q2 2021 in Review

402 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2021, worth a combined $7.78B — up 7% from $7.28B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new UTHR positions and 40 closed out — a net gain of 14 holders — while 117 added to existing stakes and 160 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $105M. The largest seller was Consonance Capital Management, cutting an estimated $76M.

  • 402 institutional investors held United Therapeutics (UTHR) as of Q2 2021, up from 391 in Q1 2021.
  • Funds reported $7.78B of United Therapeutics stock for Q2 2021, up 7% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q2 2021 and 40 closed out, a net change of +14 holders.
  • The largest United Therapeutics buyer in Q2 2021 was Point72 Asset Management, an estimated $105M added.
  • The largest United Therapeutics seller in Q2 2021 was Consonance Capital Management, an estimated $76M sold.

Based on aggregated 13F filings for Q2 2021.